Brief: Poseida Therapeutics Provides Updates And Financial Results For The First Quarter Of 2023

Poseida Therapeutics

09/05/2023 23:05

Poseida Therapeutics Inc  PSTX.O :
    * POSEIDA THERAPEUTICS PROVIDES UPDATES AND FINANCIAL
RESULTS FOR
THE FIRST QUARTER OF 2023
    * AS OF MARCH 31, 2023, CO'S CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS BALANCE WAS $247.2 MILLION
    * POSEIDA-SEES CASH,CASH EQUIVALENTS,SHORT-TERM INVESTMENTS
WITH
REMAINING NEAR-TERM MILESTONES,PAYMENTS FROM ROCHE TO FUND
OPERATIONS INTO AT LEAST MID-2024
    * QTRLY LOSS PER SHARE $0.45
    * Q1 EARNINGS PER SHARE VIEW $-0.45 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPnQW2Nva 
Further company coverage:  PSTX.O